REG - Intelligent Ultrasnd - Notice of AGM and 2023 Report and Accounts

Intelligent UltrasoundAnnouncement

23/05/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240523:nRSW5402Pa&default-theme=true

RNS Number : 5402P  Intelligent Ultrasound Group PLC  23 May 2024

Intelligent Ultrasound Group plc

(the "Group" or the "Company")

 

Notice of Annual General Meeting and

2023 Report and Accounts

 

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic'
ultrasound company, specialising in artificial intelligence (AI) software and
simulation, announces that the following documents have been posted or
otherwise been made available to shareholders:

 

·      2023 Report and Accounts; and

·      Notice of 2024 Annual General Meeting ("AGM")

 

The Notice of AGM and the 2023 Report and Accounts are also available to view
on the Company's website at:
www.intelligentultrasound.com/reports-presentations
(http://www.intelligentultrasound.com/reports-presentations)

 

The AGM will be held on Tuesday 18 June 2024 at 10.30 a.m. at Cavendish
Capital Markets Limited, One Bartholemew Close, London EC1A 7BL.

 

Details of how to participate in the Meeting and the resolutions that will be
tabled for shareholder approval are set out in the Notice of AGM.

 

For further information, please contact:

 

 Intelligent Ultrasound Group plc                  www. intelligentultrasound.com (http://intelligentultrasound.com/)
 Stuart Gall, CEO                                  Tel: +44 (0)29 2075 6534
 Helen Jones, CFO

 Cavendish Capital Markets Limited                 Tel:  +44 (0)20 7397 8900

 (Nominated Advisor and Broker)
 Giles Balleny/Dan Hodkinson (Corporate Finance)
 Nigel Birks (ECM)

 Ondraya Swanson (ECM)

 Dale Bellis (Sales)

 TB Cardew - PR Advisers                           Intelligentultrasound@tbcardew.com (mailto:Intelligentultrasound@tbcardew.com)

 Allison Connolly                                  Tel: +44 (0)7587 453955

 Emma Pascoe-Watson                                Tel: +44 (0)7774 620415

 Jessica Pilling                                   Tel: +44 (0)7918 584573

 

 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to
clinic' ultrasound companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market ('clinic'). Based in Cardiff in
the UK and Atlanta in the US, the Group has two revenue streams:

 

Simulation

Real-time hi-fidelity ultrasound education and training through simulation.
Our main products are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training simulator,
the BodyWorks Eve Point of Care and Emergency Medicine training simulator
and the BabyWorks Neonate and Paediatric training simulator. To date over
1,700 simulators have been sold to over 800 medical institutions around the
world.

 

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more
accessible using our proprietary ScanNav ultrasound image analysis
technology. Current products on the market utilising this technology are GE
HealthCare's SonoLyst software that is incorporated in their Voluson Expert,
Signature and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer
that teaches real-time ultrasound-guided needling and incorporates ScanNav
Anatomy PNB.

 

www.intelligentultrasound.com (http://www.intelligentultrasound.com/)

 

NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the
FDA but is not available for sale in any other territory requiring government
approval for this type of product.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAQKBBQABKDFPB